Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ement signaled deepening ties between Moscow and Beijing amid growing tensions in their relations with the United States." Bloomberg (10/22, Meyer, Kravchenko, 4.73M) reports Putin also urged President Trump "to agree to his proposal for a one-year extension of the New START arms-control treaty as talks e

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

/www.bloomberg.corn/news/articles/2020-10-22/putin-says-russia-willing-to-include-new-weapons-in-u- s-talks?smd=premium&sref=3IOEzKok> (10/22, Meyer, Kravchenko, 4.73M) reports Putin also urged President Trump "to agree to his proposal for a one-year extension of the New START arms-control treaty as talks en

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

tement signaled deepening ties between Moscow and Beijing amid growing tensions in their relations with the United States." Bloomberg (10/22, Meyer, Kravchenko, 4.73M) reports Putin also urged President Trump "to agree to his proposal for a one-year extension of the New START arms-control treaty as talks e